[Effects of intravenous flecainide in the treatment of paroxysmal or recent-onset atrial fibrillations].
Intravenous flecainide (2 mg/Kg for 15 min) was used in 30 patients (18 men and 12 women aged 23 to 85 years: mean 62) with recent or paroxysmal atrial fibrillation: 5 patients returned to sinus rhythm during flecainide administration while other 23 patients did it not later than 2 hours. Treatment with intravenous flecainide proved to be safe without significant side effects. Further investigations are required to define the effects of flecainide in the treatment of atrial fibrillation; at the moment it must be admitted that flecainide acetate is a useful, safe, fast acting drug for the conversion of paroxysmal or recent atrial fibrillation to sinus rhythm.
Bolognesi
R
R
Tsialtas
D
D
Manca
C
C
Visioli
O
O
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004341:Drug Evaluation; D004452:Echocardiography; D005260:Female; D005424:Flecainide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D005424:Flecainide
Effetti della flecainide endovenosa nel trattamento delle fibrillazioni atriali parassistiche o di recente insorgenza.